Veteran actress Sharmila Tagore's early-stage lung cancer diagnosis has brought attention to zero-stage lung cancer, also ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health ...

Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods ... that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations ...

NSCLC patients who stopped immunotherapy due to side effects still showed lasting disease control and survival benefits..

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

DelveInsight's data-driven approach not only illuminated the path forward but also positioned the client as a frontrunner in biomarker-driven NSCLC therapies. This case study showcases how ...